Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
114.86
-1.10 (-0.95%)
At close: Aug 17, 2026, 4:00 PM EDT
114.86
0.00 (0.00%)
After-hours: Aug 17, 2026, 7:34 PM EDT
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $6.42 billion as of August 17, 2026. Its market cap has increased by 862.37% in one year.
Market Cap
6.42B
Enterprise Value
5.24B
1-Year Change
862.37%
Ranking
Category
Stock Price
$114.86
ChartMarket Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $6.42B, an increase of 3,841.61%. That is a compound annual growth rate of 250.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 6.42B | 263.61% |
| Dec 31, 2025 | 1.77B | 173.85% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
| Sep 12, 2023 | 162.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TG Therapeutics | 6.91B |
| CG Oncology | 6.65B |
| Cogent Biosciences | 6.58B |
| Mirum Pharmaceuticals | 6.53B |
| Erasca | 6.43B |
| Belite Bio | 6.40B |
| Scholar Rock Holding | 6.40B |
| Caris Life Sciences | 6.16B |